Israel's Pitango launches $150 million health technology fund

JERUSALEM (Reuters) – Israel’s Pitango Venture Capital said on Thursday it was launching a fund that will reach $150 million to invest in health technology. The new HealthTech Fund will operate alongside Pitango’s Early Stage Tech and Growth funds, it said. In its first investment, the fund will invest $7 million in Variantyx, which has developed genomics diagnostics technologies. Pitango […]

Read more

Israel pounds targets in Gaza after surprise rocket attack

JERUSALEM — Israeli forces continued striking targets across the Gaza Strip through Tuesday, including the offices of Hamas’ supreme leader, in response to a surprise rocket attack from the Palestinian territory, as the military bolstered its troops and rocket-defense systems in anticipation of a new round of heavy fighting with the Islamic militant group. Israel opened public bomb shelters in […]

Read more

Trump Declares Golan Heights Part of Israel, Helping Netanyahu

President Donald Trump officially recognized Israeli sovereignty over the Golan Heights Monday in a ceremony with Benjamin Netanyahu, delivering a symbolic boost to the Israeli prime minister just two weeks before he faces a re-election vote. The presidential proclamation, foreshadowed last week when Trump said it was time for the change, breaks with decades of U.S. policy. “Under my administration, […]

Read more

Teva Shares Fall As Q4 Adj. Profit Misses View, Outlook Disappoints

Israel-based generic drug maker Teva Pharmaceutical Industries Ltd. (TEVA) on Wednesday reported a loss for the fourth quarter that narrowed from last year as a decline in revenues was more than offset by lower costs and expenses. However, adjusted earnings per share missed analysts’ expectations, while revenues beat estimates. Looking ahead, Teva provided its financial outlook for fiscal 2019 also […]

Read more

U.S. settles with Teva over keeping generic drugs off market

WASHINGTON (Reuters) – The U.S. government has reached a settlement with Teva Pharmaceuticals Industries Ltd over charges that its agreements with rivals impeded consumer access to lower-priced generic drugs. The Federal Trade Commission on Tuesday said it had settled three reverse payment fights with units of Teva, which will be prohibited from making any similar agreements with competitors in the […]

Read more

Teva Shares Fall As Q4 Adj. Profit Misses View, Outlook Disappoints

Israel-based generic drug maker Teva Pharmaceutical Industries Ltd. (TEVA) on Wednesday reported a loss for the fourth quarter that narrowed from last year as a decline in revenues was more than offset by lower costs and expenses. However, adjusted earnings per share missed analysts’ expectations, while revenues beat estimates. Looking ahead, Teva provided its financial outlook for fiscal 2019 also […]

Read more

Intel plans to invest $11 billion in new Israeli chip plant: report

(Reuters) – U.S. chipmaker Intel plans to spend 40 billion shekels ($10.89 billion) to build a new manufacturing plant in Israel and has asked the Israeli government for a grant amounting to 10 percent of the amount, a local news website reported on Monday. Talks on the investment between Intel and Israel’s Ministry of Finance began weeks ago and are […]

Read more
1 2 3 9